Trends of Blood Transfusion Services before and during COVID-19 Pandemic- A Retrospective Study from Maharashtra, India
Correspondence Address :
Dr. Shweta Wasudeo Dhote,
Department of Transfusion Medicine, Mahatma Gandhi Mission Institute of Health
Sciences, Navi Mumbai, Maharashtra, India.
Introduction: Coronavirus Disease 2019 (COVID-19) affected the usual number of blood donations as well as the component utilisation in routine use severely. Directions by government to maintain social distancing and avoidance of social gatherings resulted in lesser number of voluntary blood donation camps. This resulted in blood scarcity.
Aim: To assess the impact on pattern of usage of blood components previously and during COVID-19 pandemic.
Materials and Methods: This was a retrospective study, conducted in Department of Immunohaematology and Transfusion Medicine (Blood Centre) of a tertiary care hospital, Navi Mumbai, Maharashtra, India. The study was carried out for a period of two years i.e., from April 2019 to March 2021. The study was divided into two phases. Phase I- April 2019 to March 2020, Phase II- April 2020 to March 2021. Data was collected retrospectively from the donor registers and camp reports. Blood components utilisation data was collected from issue registers. Microsoft Excel and Microsoft Word were used to compile the data. Basic descriptive statistics and graphs were prepared using Statistical Package for the Social Sciences (SPSS). Independent t-test was applied to assess the difference in mean and Standard Deviation (SD) between two phases. The p-value p<0.05 was considered as significant.
Results: A total of 6,060 units were collected during the phase I whereas 3,433 units were collected during the phase II. Mean number of units received during phase I were significantly higher (505Â±127.2) as compared to phase II (286.1±73.9) (p<0.05). Overall, utilisation of Packed Red Blood Cell (PRBC), Random Donor Platelet/Single Donor Platelet (RDP/SDP) and Fresh Frozen Plasma (FFP) was significantly higher in phase I as compared to phase II (p<0.05).
Conclusion: Every day, our understanding of the COVID-19 epidemic grows. An effective communication strategy with voluntary blood donors to urge them to donate, as well as networking with neighbouring blood centres, will go a long
Blood products, Convalescent plasma, Utilisation, Voluntary blood donor
Date of Submission: Aug 28, 2021
Date of Peer Review: Sep 28, 2021
Date of Acceptance: Nov 16, 2021
Date of Publishing: Dec 01, 2021
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? NA
• For any images presented appropriate consent has been obtained from the subjects. NA
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Aug 31, 2021
• Manual Googling: Nov 16, 2021
• iThenticate Software: Nov 29, 2021 (19%)
ETYMOLOGY: Author Origin
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)